Genomic characterization of JG068, a novel virulent podovirus active against Burkholderia cenocepacia

Comparative analysis of two phenotypically-similar but genomically-distinct Burkholderia cenocepacia-specific bacteriophages

(2012) Karlene H Lynch et al.   BMC GENOMICS

Cangene Gold Medal Award Lecture — Genomic analysis and modification of Burkholderia cepacia complex bacteriophages1This article is based on a presentation by Dr. Karlene Lynch at the 61st Annual Meeting of the Canadian Society of Microbiologists in St. John’s, Newfoundland and Labrador, on 21 June 2011. Dr. Lynch was the recipient of the 2011 Cangene Gold Medal as the Canadian Graduate Student Microbiologist of the Year, an annual award sponsored by Cangene Corporation intended to recognize excellence in graduate research.

(2012) Karlene H. Lynch et al.   CANADIAN JOURNAL OF MICROBIOLOGY

Bacteriophages LIMElight and LIMEzero of Pantoea agglomerans, Belonging to the “phiKMV-Like Viruses”

(2011) Evelien M. Adriaenssens et al.   APPLIED AND ENVIRONMENTAL MICROBIOLOGY

Characterization of DC1, a Broad-Host-Range Bcep22-Like Podovirus

(2011) Karlene H. Lynch et al.   APPLIED AND ENVIRONMENTAL MICROBIOLOGY

Sequencing and Characterization of Pseudomonas aeruginosa phage JG004

(2011) Julia Garbe et al.   BMC MICROBIOLOGY

Genomes and Characterization of Phages Bcep22 and BcepIL02, Founders of a Novel Phage Type in Burkholderia cenocepacia

(2011) J. J. Gill et al.   JOURNAL OF BACTERIOLOGY

Genomic analysis and relatedness of P2-like phages of the Burkholderia cepacia complex

(2010) Karlene H Lynch et al.   BMC GENOMICS

Experimental Bacteriophage Therapy Increases Survival of Galleria mellonella Larvae Infected with Clinically Relevant Strains of the Burkholderia cepacia Complex

(2009) K. D. Seed et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistantPseudomonas aeruginosa; a preliminary report of efficacy

(2009) A. Wright et al.   CLINICAL OTOLARYNGOLOGY

Biosynthesis and Structure of theBurkholderia cenocepaciaK56-2 Lipopolysaccharide Core Oligosaccharide

(2009) Ximena Ortega et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Efficacy of Bacteriophage Therapy in a Model ofBurkholderia cenocepaciaPulmonary Infection

(2009) Lisa A. Carmody et al.   JOURNAL OF INFECTIOUS DISEASES

Inactivation of Burkholderia cepacia Complex Phage KS9 gp41 Identifies the Phage Repressor and Generates Lytic Virions

(2009) K. H. Lynch et al.   JOURNAL OF VIROLOGY

Quality-Controlled Small-Scale Production of a Well-Defined Bacteriophage Cocktail for Use in Human Clinical Trials

(2009) Maya Merabishvili et al.   PLoS One

OCTOPUS: improving topology prediction by two-track ANN-based preference scores and an extended topological grammar

(2008) Håkan Viklund et al.   BIOINFORMATICS

Genomic sequence and activity of KS10, a transposable phage of the Burkholderia cepacia complex

(2008) Amanda D Goudie et al.   BMC GENOMICS

Development of Galleria mellonella as an Alternative Infection Model for the Burkholderia cepacia Complex

(2008) K. D. Seed et al.   INFECTION AND IMMUNITY

Genomic Characterization of Ralstonia solanacearum Phage  RSB1, a T7-Like Wide-Host-Range Phage

(2008) T. Kawasaki et al.   JOURNAL OF BACTERIOLOGY

Unifying classical and molecular taxonomic classification: analysis of the Podoviridae using BLASTP-based tools

(2008) Rob Lavigne et al.   RESEARCH IN MICROBIOLOGY